Formula Growth’s UiPath PATH Stock Holding History

Formula Growth’s Portfolio PATH Stock Details PATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-225,000	Closed	-$4.09M	–	136
2022 Q2	$4.09M	Sell	225,000 -100,000	-31%	-$1.87M	1.13%	33
2022 Q1	$7.02M	Buy	+325,000	New	+$11M	1.32%	21

Other funds holding PATH

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

AGFIA

Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Formula Growth's PATH Position: Q3 2022 in Review

Formula Growth sold out of UiPath (PATH) in Q3 2022, closing a stake of 225,000 shares — an estimated $4.09M sold.

Formula Growth first reported a position in PATH in Q1 2022 and held it in 2 quarters. The position peaked at $7.02M in Q1 2022. 302 funds tracked by Wall St. Rank hold PATH as of Q3 2022.

Formula Growth reported no remaining UiPath position as of Q3 2022 after selling out during the quarter.
Formula Growth sold 225,000 UiPath shares in Q3 2022, an estimated $4.09M.
Formula Growth first reported a position in UiPath in Q1 2022 and held it in 2 quarters.
Formula Growth's UiPath position peaked at $7.02M in Q1 2022.
302 funds tracked by Wall St. Rank held UiPath as of Q3 2022.

Based on Formula Growth's 13F filing for Q3 2022, filed 10 Nov 2022.